C0614

(±) Clopidogrel hydrogensulfate

≥98% (HPLC), ADP-induced platelet aggregation inhibitor, powder

• Synonym(s): Methyl (2-chlorophenyl)(6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl)acetate hydrogen sulfate, SR-25990
• Empirical Formula (Hill Notation): C₁₆H₁₆ClNO₂S · H₂SO₄
• CAS Number: 135046-48-9
• Molecular Weight: 419.90
• UNSPSC Code: 51111800
• PubChem Substance ID: 329774806
• NACRES: NA.77
• MDL number: MFCD05865229
• Assay: ≥98% (HPLC)
• Form: powder
• Quality level: 100
• Storage condition: desiccated

Properties

• Product Name: (±) Clopidogrel hydrogensulfate, ≥98% (HPLC), powder
• Quality Level: 100
• assay: ≥98% (HPLC)
• form: powder
• storage condition: desiccated
• color: white
• solubility: DMSO: ~26 mg/mL
• originator: Bristol-Myers Squibb
• storage temp.: 2-8°C
• SMILES string: OS(O)(=O)=O.COC(=O)C(N1CCc2sccc2C1)c3ccccc3Cl

Description

Biochem/physiol Actions

Inhibits ADP-induced platelet aggregation; anti-thrombotic drug.

Features and Benefits

This compound is a featured product for ADME Tox research. Click here to discover more featured ADME Tox products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm.

This compound is featured on the P2 Receptors: P2Y G-Protein Family page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.

This compound was developed by Bristol-Myers Squibb. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Packaging

Store under desiccant

Safety Information

• pictograms: GHS05,GHS09
• signalword: Danger
• hcodes: H314,H411
• pcodes: P260 - P273 - P280 - P303 + P361 + P353 - P304 + P340 + P310 - P305 + P351 + P338
• Hazard Classifications: Aquatic Chronic 2 - Eye Dam. 1 - Skin Corr. 1B
• Storage Class: 8A - Combustible corrosive hazardous materials
• wgk: WGK 3
• flash_point_f: Not applicable
• flash_point_c: Not applicable
• ppe: Eyeshields, Gloves, type N95 (US)